Women and Psychedelics

The experiences of women with psychedelic medicines have been shaped by a set of factors that differ significantly from those of the predominantly male populations that have dominated research samples, clinical trials, and public conversations about these substances. Attending to these differences is not a niche concern; it reflects the reality that the physiological, social, and psychological dimensions of psychedelic experience are gendered in ways that matter for both safety and outcome.

Physiologically, women tend to experience more intense and longer-lasting effects at equivalent doses, likely related to differences in body weight, body fat distribution, and hormonal factors that affect drug metabolism. Many women report that the phase of their menstrual cycle affects the character of their experience: some find experiences more emotionally intense and internally oriented during certain phases, while the same dose at a different phase produces a noticeably different character. Few formal studies have examined this systematically, leaving this domain largely in the territory of anecdotal observation.

The social and relational dimensions of women's experiences with these medicines involve specific safety considerations. Sexual abuse and boundary violations in ceremonial settings have been documented with enough frequency to constitute a serious systemic concern rather than isolated incidents. Several prominent shamans and facilitators have faced credible accusations. The power differential between healer and participant, combined with the vulnerability of an altered state, creates conditions that have been exploited. Awareness of these risks, and the importance of trustworthy facilitators and support structures, is especially relevant.

In therapeutic contexts, women's emotional processing styles and relational orientations are sometimes more compatible with the interpersonal dimensions of psychedelic therapy - the presence of a trusted guide, the capacity to move through relational material. This is a generalization with many exceptions, but it has been noted by clinicians working in this space.

Women have also played central roles in the development and preservation of these traditions - from the Mazatec healer Maria Sabina, who shared psilocybin mushroom ceremonies with R. Gordon Wasson, to contemporary researchers, therapists, and ceremonial practitioners. Their contributions have sometimes been credited inadequately.